Page last updated: 2024-11-07

prednisone and Lymphangioleiomyoma

prednisone has been researched along with Lymphangioleiomyoma in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wellens, F1
Estenne, M1
de Francquen, P1
Goldstein, J1
Leclerc, JL1
Primo, G1

Other Studies

1 other study available for prednisone and Lymphangioleiomyoma

ArticleYear
Combined heart-lung transplantation for terminal pulmonary lymphangioleiomyomatosis.
    The Journal of thoracic and cardiovascular surgery, 1985, Volume: 89, Issue:6

    Topics: Adult; Azathioprine; Bronchial Diseases; Cyclosporins; Female; Heart Transplantation; Heart-Lung Tra

1985